Matthew Stork, Chief Executive Officer at Cambridge Cognition said: “We are delighted to have received an order from a leading pharmaceutical company to trial the NeuroVocalix™ platform. We are also
Matthew Stork, CEO of Cambridge Cognition said: “We are delighted that Debra has joined the Board. Debra brings with her an immense amount of knowledge and expertise in successful global
The neuroscience technology company Cambridge Cognition Holdings PLC (LON:COG), which develops and markets neuroscience technologies to assess brain health, has announced today that it will be hosting a Capital Markets
Cambridge Cognition’s Matthew Stork discusses his background, what he brings to the company and growth drivers going forward in this exclusive interview with DirectorsTalk
Cambridge Cognition Holdings plc (LON: COG) new COO Matthew Stork joins DirectorsTalk to talk about his move to the company. Matthew provides us with detail around his career, explains why he
Cambridge Cognition Holdings plc (LON: COG), which develops and markets neuroscience technology to assess brain health, has confirmed this morning that the Annual Report and Accounts for the year ended 31
Cambridge Cognition Holdings plc (LON:COG), which develops and markets neuroscience technology to assess brain health, announces a number of changes to the Board of Directors which will take effect following
The neuroscience technology company Cambridge Cognition Holdings plc (LON: COG), which develops and markets neuroscience technologies to assess brain health, announces that on 16 April 2019, the Company granted options over a
Dr Steven Powell, Chief Executive Officer, Cambridge Cognition said: “Following the recent share placing to finance the expansion of our operations and strengthening of the balance sheet we are pleased
Commenting on the results Steven Powell, Chief Executive Officer, said: “The funds secured today will enable us to accelerate our development in two key growth areas of eCOA and Digital
© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
